Sunday, April 02, 2017
There have been two international cases reported where the defective part prevented the auto-injector from activating (no cases confirmed in Canada).
The products involved in the recall are EpiPen auto-injectors with an expiry date of May 2017 and EpiPen Jr. auto-injectors with an expiry date of March 2017.
The company says that in total, more than 100,000 products that could be affected were distributed in Canada.
Click here for more details.